Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karlen, S
Right arrow Articles by Sanderson, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karlen, S
Right arrow Articles by Sanderson, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Two pathways can activate the interleukin-5 gene and induce binding to the conserved lymphokine element 0

S Karlen, M D'Ercole and CJ Sanderson

TVW Telethon Institute for Child Health Research, Perth, Australia.

Eosinophilia is a uniquely specific phenomenon regulated by interleukin- 5 (IL-5), suggesting specific control for IL-5 gene expression. Using a transient-transfection reporter assay and DNA mobility-shift experiments in EL4 mouse lymphoma cells, reporter expression and binding of transcription factors to the conserved lymphokine element 0 (CLE0) in the mouse (mIL-5) promoter was investigated. Activation of the IL-5 promoter required costimulation of T cells with phorbol ester (phorbol 12-myristate 13-acetate [PMA]) and cyclic adenosine 3',5'- monophosphate (cAMP), but was blocked by the immunosuppressive drug, cyclosporin A (CsA). Binding to CLE0 was induced under conditions optimal for IL-5 transcription but was not blocked by CsA. CD28-induced signals could partly substitute for cAMP. However, the effects of cAMP, but not of CD28, were sensitive to the cAMP-dependent protein kinase inhibitor, H89, suggesting that CD28 does not involve a cAMP mechanism. It therefore appears that IL-5 expression can be induced by at least two distinct stimulatory pathways. Although CLE0 contains sequences similar to AP-1 and NF-AT, only the AP-1 moiety of the CLE0 element could be demonstrated to have inducible binding. Experiments with antisera to the AP-1 family of transcription factors indicated that c- fos and JunB bind to the IL-5 CLE0 in activated lymphoma cells. The role of the NF-AT-like element was less clear. A constitutively expressed protein showed a weak band that was inhibited by mIL-2 NF-AT competitor sequences. However, this protein did not react with an anti- NF-ATp antiserum. On the other hand, transcription was partially inhibited by an oligonucleotide containing the intact NF-AT-like element from CLE0, suggesting that the element is important for optimal transcription, but the nature of the protein binding to it remains unknown. The fact that these factors are induced in a subclone of EL4 that does not express IL-5 and bind to a number of other cytokine gene promoters suggests that although binding to CLE0 appears to be necessary for IL-5 transcription, other factors must control the specific expression of the gene.

Volume 88, Issue 1, pp. 211-221, 07/01/1996
Copyright © 1996 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Int ImmunolHome page
J. Wang, M. F. Shannon, and I. G. Young
A role for Ets1, synergizing with AP-1 and GATA-3 in the regulation of IL-5 transcription in mouse Th2 lymphocytes
Int. Immunol., February 1, 2006; 18(2): 313 - 323.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. T. F. Schwenger, C. C. Kok, E. Arthaningtyas, M. A. Thomas, C. J. Sanderson, and V. A. Mordvinov
Specific Activation of Human Interleukin-5 Depends on de Novo Synthesis of an AP-1 Complex
J. Biol. Chem., November 27, 2002; 277(49): 47022 - 47027.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. S. Salerno, V. A. Mordvinov, and C. J. Sanderson
Binding of Octamer Factors to a Novel 3'-Positive Regulatory Element in the Mouse Interleukin-5 Gene
J. Biol. Chem., February 11, 2000; 275(6): 4525 - 4531.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. R. Johnson and B. S. Graham
Secreted Respiratory Syncytial Virus G Glycoprotein Induces Interleukin-5 (IL-5), IL-13, and Eosinophilia by an IL-4-Independent Mechanism
J. Virol., October 1, 1999; 73(10): 8485 - 8495.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Nishiyama, T. Yokota, K. Okumura, and C. Ra1
The Transcription Factors Elf-1 and GATA-1 Bind to Cell-Specific Enhancer Elements of Human High-Affinity IgE Receptor {alpha}-Chain Gene
J. Immunol., July 15, 1999; 163(2): 623 - 630.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
F. H. Krouwels, B. E. A. Hol, R. Lutter, B. Bruinier, A. Bast, H. M. Jansen, and T. A. Out
Histamine Affects Interleukin-4, Interleukin-5, and Interferon-gamma Production by Human T Cell Clones from the Airways and Blood
Am. J. Respir. Cell Mol. Biol., May 1, 1998; 18(5): 721 - 730.
[Abstract] [Full Text]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
F. G. Rolfe, J. E. Valentine, and W. A. Sewell
Cyclosporin A and FK506 Reduce Interleukin-5 mRNA Abundance by Inhibiting Gene Transcription
Am. J. Respir. Cell Mol. Biol., August 1, 1997; 17(2): 243 - 250.
[Abstract] [Full Text]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1996 by American Society of Hematology         Online ISSN: 1528-0020